656 related articles for article (PubMed ID: 25991041)
1. C4d as a Diagnostic Tool in Proliferative GN.
Sethi S; Nasr SH; De Vriese AS; Fervenza FC
J Am Soc Nephrol; 2015 Nov; 26(11):2852-9. PubMed ID: 25991041
[TBL] [Abstract][Full Text] [Related]
2. C4d Staining in the Diagnosis of C3 Glomerulopathy.
Cook HT
J Am Soc Nephrol; 2015 Nov; 26(11):2609-11. PubMed ID: 25991042
[No Abstract] [Full Text] [Related]
3. C4 Glomerulopathy: A Disease Entity Associated With C4d Deposition.
Sethi S; Quint PS; O'Seaghdha CM; Fervenza FC; Bijol V; Dorman A; Dasari S; Smith RJ; Kurtin PJ; Rennke HG
Am J Kidney Dis; 2016 Jun; 67(6):949-53. PubMed ID: 26896898
[TBL] [Abstract][Full Text] [Related]
4. Use of C4d as a diagnostic tool to classify membranoproliferative glomerulonephritis.
Gupta N; Wakefield DN; Clapp WL; Garin EH
Nefrologia; 2017; 37(1):78-86. PubMed ID: 27595516
[TBL] [Abstract][Full Text] [Related]
5. C4d at Crossroads Between Post-Infectious Glomerulonephritis and C3 Glomerulopathy.
Bashir S; Hussain M; Afzal A; Hassan U; Hameed M; Mushtaq S
Int J Nephrol Renovasc Dis; 2021; 14():87-95. PubMed ID: 33732010
[TBL] [Abstract][Full Text] [Related]
6. Utility of C4d Immunohistochemistry as an Adjunct Stain in Diagnostic Renal Pathology of Glomerular Diseases.
Pradeep I; Srinivas BH
Int J Surg Pathol; 2024 Feb; 32(1):21-26. PubMed ID: 37143311
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and Pathophysiology of Glomerular C4d Staining in Native Kidney Biopsies.
Drachenberg CB; Papadimitriou JC; Chandra P; Haririan A; Mendley S; Weir MR; Rubin MF
Kidney Int Rep; 2019 Nov; 4(11):1555-1567. PubMed ID: 31890997
[TBL] [Abstract][Full Text] [Related]
8. Standardized classification and reporting of glomerulonephritis.
Sethi S; Fervenza FC
Nephrol Dial Transplant; 2019 Feb; 34(2):193-199. PubMed ID: 30124958
[TBL] [Abstract][Full Text] [Related]
9. C3 Glomerulopathy and Related Disorders in Children: Etiology-Phenotype Correlation and Outcomes.
Wong EKS; Marchbank KJ; Lomax-Browne H; Pappworth IY; Denton H; Cooke K; Ward S; McLoughlin AC; Richardson G; Wilson V; Harris CL; Morgan BP; Hakobyan S; McAlinden P; Gale DP; Maxwell H; Christian M; Malcomson R; Goodship THJ; Marks SD; Pickering MC; Kavanagh D; Cook HT; Johnson SA;
Clin J Am Soc Nephrol; 2021 Nov; 16(11):1639-1651. PubMed ID: 34551983
[TBL] [Abstract][Full Text] [Related]
10. Glomerular C4d deposition in proliferative glomerular diseases.
Raman S; Mishra P; Panigrahi A; Rout NK; Dash K
Indian J Pathol Microbiol; 2021; 64(1):69-77. PubMed ID: 33433412
[TBL] [Abstract][Full Text] [Related]
11. Incidental healed postinfectious glomerulonephritis: a study of 1012 renal biopsy specimens examined by electron microscopy.
Haas M
Hum Pathol; 2003 Jan; 34(1):3-10. PubMed ID: 12605360
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of immunofluorescence versus immunoperoxidase staining to distinguish immune complex-mediated glomerulonephritis and C3 dominant glomerulopathy.
Bouatou Y; Kers J; Chevalier-Florquin MSN; Claessen N; Nguyen TQ; Damman J; Proença H; Roelofs JJTH; Florquin S
Histopathology; 2018 Mar; 72(4):601-608. PubMed ID: 28881045
[TBL] [Abstract][Full Text] [Related]
13. The role of complement in C3 glomerulopathy.
Zipfel PF; Skerka C; Chen Q; Wiech T; Goodship T; Johnson S; Fremeaux-Bacchi V; Nester C; de Córdoba SR; Noris M; Pickering M; Smith R
Mol Immunol; 2015 Sep; 67(1):21-30. PubMed ID: 25929733
[TBL] [Abstract][Full Text] [Related]
14. Utility of immunohistochemistry with C3d in C3 glomerulopathy.
Snijders MLH; van de Wall-Neecke BJ; Hesselink DA; Becker JU; Clahsen-van Groningen MC
Mod Pathol; 2020 Mar; 33(3):431-439. PubMed ID: 31477814
[TBL] [Abstract][Full Text] [Related]
15. Membranoproliferative glomerulonephritis and C3 glomerulonephritis: frequency, clinical features, and outcome in children.
Okuda Y; Ishikura K; Hamada R; Harada R; Sakai T; Hamasaki Y; Hataya H; Fukuzawa R; Ogata K; Honda M
Nephrology (Carlton); 2015 Apr; 20(4):286-92. PubMed ID: 25524631
[TBL] [Abstract][Full Text] [Related]
16. Dominant C3 glomerulopathy: new roles for an old actor in renal pathology.
Pirozzi N; Stoppacciaro A; Menè P
J Nephrol; 2018 Aug; 31(4):503-510. PubMed ID: 29151252
[TBL] [Abstract][Full Text] [Related]
17. Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement.
Sethi S; Fervenza FC; Zhang Y; Nasr SH; Leung N; Vrana J; Cramer C; Nester CM; Smith RJ
Clin J Am Soc Nephrol; 2011 May; 6(5):1009-17. PubMed ID: 21415311
[TBL] [Abstract][Full Text] [Related]
18. Pathology of renal diseases associated with dysfunction of the alternative pathway of complement: C3 glomerulopathy and atypical hemolytic uremic syndrome (aHUS).
Sethi S; Fervenza FC
Semin Thromb Hemost; 2014 Jun; 40(4):416-21. PubMed ID: 24799306
[TBL] [Abstract][Full Text] [Related]
19. [Immune complexes and C3 and C4 of the complement in urine of patients with glomerulonephritis].
Kacprzyk F; Chrzanowski W
Pol Arch Med Wewn; 1996 Sep; 96(3):215-23. PubMed ID: 9122012
[TBL] [Abstract][Full Text] [Related]
20. Toward a working definition of C3 glomerulopathy by immunofluorescence.
Hou J; Markowitz GS; Bomback AS; Appel GB; Herlitz LC; Barry Stokes M; D'Agati VD
Kidney Int; 2014 Feb; 85(2):450-6. PubMed ID: 24067430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
